Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07317115

Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes

Led by GT Metabolic Solutions, Inc. · Updated on 2026-02-20

20

Participants Needed

1

Research Sites

117 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Compare use of the Magnet System in side-to-side duodeno-ileostomy (Surgery) with semaglutide (Medication).

CONDITIONS

Official Title

Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Body Mass Index (BMI) between 30 - 40 kg/m2 and qualifies for obesity treatment at the discretion of the treating investigator
  • Type 2 diabetes (T2D) defined as HbA1c 65 6.5%
  • Participant agrees to avoid additional metabolic and bariatric surgery affecting body weight during the study
  • Participant agrees not to take any additional semaglutide-containing or other GLP-1RA medications during the study
  • Participant is willing and able to comply with study requirements and provides written informed consent
Not Eligible

You will not qualify if you...

  • Has contraindications for either treatment arm (Magnet System surgery or semaglutide medication) prohibiting randomization
  • Had metabolic and bariatric surgery within the previous 12 months
  • Took semaglutide, semaglutide-containing medications, or any other GLP-1RA medication in the previous 12 months
  • Is pregnant, lactating, or planning pregnancy during the study and follow-up period
  • Currently participating in another investigational drug, biologic, or medical device study
  • Has other anatomic, medical, social, or psychological conditions that contraindicate treatment or limit study participation or compliance

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Westmount Surgical Center

Westmount, Quebec, Canada, H3Z 2P9

Actively Recruiting

Loading map...

Research Team

L

Lisa Griffin Vincent, PhD, MA

CONTACT

J

Josh Schumacher

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Side-to-Side Duodeno-ileostomy Versus Semaglutide in Adults With Obesity and Type 2 Diabetes | DecenTrialz